Caplight Directory>Investors>Roche Venture Fund>Roche-venture-fund


Roche Venture Fund

Roche Venture Fund

Basel, Basel-Stadtventurefund.roche.com

Overview

The Roche Venture Fund is the corporate venture fund of Roche, a global leader in bringing medicines and in vitro diagnostics to the benefit of patients . They invest in life science companies aiming to create value by fostering innovation, guiding successful businesses and generating financial return to Roche . The fund focuses on investments in early-stage life science companies operating in the pharmaceuticals, diagnostics and digital health sectors .

Year Founded

2002

Portfolio Companies

25

Investments

CompanyDateStageLead
Mission TherapeuticsOct 2025Series D ExtensionLead
Splice BioJun 2025Series BCo-investor
Mission TherapeuticsMar 2024Series DLead
Cour PharmaJan 2024Series A-
GlycoEraJan 2024Series A ExtensionCo-investor
View all investments

Key People

Nardjess Nawel Laroussi

Patient Journey Partner

Sami FILALI

Patient Journey Partner

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersBasel, Basel-Stadt
Year Founded2002

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.